PIK3CA and cancer: In 2015, Anglesio et al demonstrated that clear-cell ovarian carcinomas shared many mutations with associated concurrent endometriosis lesions, including mutations in ARID1A. Shared mutations in PIK3CA were also detected between endometriosis and clear-cell lesions, an event occurring in early progression mechanisms in other cancer types [54].